DTIL
PRECISION BIOSCIENCES INC
NASDAQ · Healthcare · Biotechnology · US
$7.86
+12.77%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 25.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.24x
- Price / sales
- 4.87x
- Price / cash flow
- -4.24x
Enterprise value
- Enterprise value
- $139.4M
- EV / sales
- 3.09x
- EV / EBITDA
- -2.86x
- EV / EBIT
- -3.86x
- Market cap
- $219.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026